Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4Thoracic 3Lymphoid 3Plasma cell 2Breast 2Other neoplasm 1Other hematologic neoplasm 1Head & Neck 1Dermatologic 1

Conditions

Immunoglobulin Light-chain Amyloidosis 2Amyloidosis 2Amyloidosis, Familial 1AA amyloidosis 1

Interventions

Dexamethasone 374Lenalidomide 206Bortezomib 201Cyclophosphamide 178Melphalan 135Calcium Dobesilate 120daratumumab 107pomalidomide 74carfilzomib 74fludarabine phosphate 71Peripheral Blood Stem Cell Transplantation 66Thalidomide 57Filgrastim 57Mycophenolic Acid 56Busulfan 55Tacrolimus 48Granulocyte Colony-Stimulating Factor 47ixazomib 45fludarabine 45Whole-Body Irradiation 44dexamethasone acetate 36Cyclosporine 35isatuximab 34Etoposide 34Antilymphocyte Serum 32dexamethasone 21-phosphate 30elotuzumab 28auricularum 27Prednisone 27plerixafor 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Doxycycline × Plasma cell × Clear all
NCT02207556 2021-07-09

DUAL

Medical College of Wisconsin

Phase 2 Completed
32 enrolled 15 charts
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT01677286 2017-08-01

Safety and Effect of Doxycycline in Patients With Amyloidosis

Boston University

Phase 2 Completed
25 enrolled 13 charts
Plasma cell

AA amyloidosis, Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Amyloidosis, Familial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡